论文部分内容阅读
Background: Peripheral neuropathy is the dose-limiting toxicity of bortezomib in multiple myeloma (MM) patients.Objective: To examine the safety, feasibility and efficacy of acupuncture in reducing bortezomib-induced peripheral neuropathy (BIPN) symptoms.